NSMCE1 Human

Non-SMC Element 1 Human Recombinant
Shipped with Ice Packs
In Stock

Description

NSMCE1 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 289 amino acids (1-266) and having a molecular mass of 33.0kDa.
NSMCE1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
NSMCE1 is a part of the SMC5-SMC6 complex, a complex that plays a role in repairing DNA double-strand breaks through a process called homologous recombination. This complex might encourage sister chromatid homologous recombination by bringing the SMC1-SMC3 cohesin complex to the sites of double-strand breaks. It's essential for maintaining telomeres (ends of chromosomes) through recombination in ALT (alternative lengthening of telomeres) cell lines. NSMCE1 also helps attach a molecule called SUMO to shelterin complex (which protects telomeres) components, a process thought to lead to the disassembly of the shelterin complex in ALT-associated PML bodies (APBs). In laboratory settings, NSMCE1 shows ubiquitin ligase activity when NDNL2 is present.
Description
Recombinant human NSMCE1, produced in E. coli bacteria, is a single polypeptide chain that lacks glycosylation. It contains 289 amino acids (specifically, amino acids 1 to 266) and has a molecular weight of 33.0 kDa. This NSMCE1 protein has a 23 amino acid His-tag attached to its N-terminus and is purified using specialized chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The NSMCE1 solution is prepared in a buffer containing 20mM Tris-HCl (pH 8.0), 0.15M NaCl, 1mM DTT, and 20% glycerol.
Stability
For short-term storage (2-4 weeks), keep refrigerated at 4°C. For longer storage, freeze at -20°C. Adding a carrier protein like HSA or BSA (0.1%) is recommended for extended storage. Avoid repeated freezing and thawing.
Purity
Purity is greater than 95% as determined by SDS-PAGE analysis.
Synonyms
Non-SMC Element 1 Homolog (S. Cerevisiae), NSE1, Non-Structural Maintenance of Chromosomes Element 1 Homolog, Non-SMC Element 1 Homolog, EC 6.3.2.-. 
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMQGSTRR MGVMTDVHRR FLQLLMTHGV LEEWDVKRLQ THCYKVHDRN ATVDKLEDFI NNINSVLESL YIEIKRGVTE DDGRPIYALV NLATTSISKM ATDFAENELD LFRKALELII DSETGFASST NILNLVDQLK GKKMRKKEAE QVLQKFVQNK WLIEKEGEFT LHGRAILEME QYIRETYPDA VKICNICHSL LIQGQSCETC GIRMHLPCVA KYFQSNAEPR CPHCNDYWPH EIPKVFDPEK ERESGVLKSN KKSLRSRQH

Q&A

Basic Research Questions

  • What is NSMCE1 and what is its fundamental role in human cells?

NSMCE1 (NSE1 homolog, SMC5-SMC6 complex component) is a protein-coding gene located on chromosome 16 that functions as a RING-type zinc finger-containing E3 ubiquitin ligase. It forms part of the essential SMC5/6 complex involved in maintaining genome integrity. Methodologically, researchers can identify NSMCE1's function through immunoprecipitation and western blot analysis, which confirms its role in forming complexes with melanoma antigen protein (MAGE) to facilitate ubiquitin transfer from E2 ubiquitin-conjugating enzymes to specific substrates .

  • How does NSMCE1 contribute to genomic stability maintenance?

NSMCE1 plays a critical role in maintaining genomic stability through several mechanisms that can be studied using specialized techniques. Flow cytometry and DNA damage assays reveal that NSMCE1 is essential for normal cell cycle progression and DNA damage response. Research methodologies using CRISPR gene editing to create NSMCE1-Knockout cell lines (N1-KO) demonstrate its essential role in cell proliferation. NSMCE1 positively regulates homologous recombination-mediated DNA repair, which researchers can investigate by comparing DNA repair efficiency in wild-type versus NSMCE1-deficient cells .

  • What structural features characterize the NSMCE1 protein?

NSMCE1 contains a highly conserved RING domain with specific cysteine and histidine residues that are critical for its function. Comparative sequence analysis between species (including human, mouse, and yeast) reveals eight highly conserved regions, indicating strong evolutionary selection pressure. The cross-braced RING-like structure in human NSMCE1 appears more tightly packed than in yeast counterparts, suggesting species-specific functional adaptations. Researchers can study these structural features through sequence alignment tools and structural modeling approaches to identify critical functional domains .

Species ComparisonStructural FeatureConservation Status
Homo sapiensRING domainHighly conserved cysteine and histidine residues
Mus musculusRING domainHighly conserved cysteine and histidine residues
S. cerevisiaeRING domainMore loosely packed structure than human
S. pombeRING domainContains conserved C/H residues but structural differences
  • What diseases are associated with NSMCE1 dysfunction?

NSMCE1 dysfunction has been associated with several diseases, including endometrial cancer, esophageal cancer, asthma (both childhood onset and allergic variants), proteasome-associated autoinflammatory syndrome 5, familial apolipoprotein C-II deficiency, familial lipoprotein lipase deficiency, severe congenital hypochromic anemia with ringed sideroblasts, 46,XX ovotesticular disorder of sex development, and sideroblastic anemia 3. To investigate these disease associations, researchers should employ case-control studies, gene expression profiling of patient samples, and functional assays in disease-relevant cell types to establish causal relationships rather than mere correlations .

Advanced Research Questions

  • How can researchers effectively investigate the structural versus enzymatic roles of NSMCE1?

To differentiate between NSMCE1's structural and enzymatic functions, researchers should employ a combinatorial approach using mutant NSMCE1 cell lines. This includes creating RING domain mutants (e.g., NSMCE1-C191A,C194A) that maintain structural integrity but lack E3 ligase activity. Comparative studies between wild-type NSMCE1, NSMCE1-knockout, and RING-mutant cell lines using immunoprecipitation and western blot analysis can identify which cellular functions depend on the structural presence of NSMCE1 versus its enzymatic activity. For example, research has demonstrated that while a functional NSMCE1 RING domain is not required for SMC5/6 complex formation, it is necessary for normal cell growth and division .

  • What experimental approaches are most effective for studying NSMCE1's role in DNA damage response?

To study NSMCE1's role in DNA damage response, researchers should implement multiple complementary approaches:

  • Generate stable cell lines with wild-type, knockout, and RING-mutant NSMCE1 using CRISPR-Cas9 gene editing

  • Assess DNA damage repair kinetics using immunofluorescence microscopy to track repair factors (e.g., γH2AX, RAD51)

  • Employ flow cytometry to analyze cell cycle progression following DNA damage induction

  • Use comet assays to directly measure DNA strand breaks

  • Perform homologous recombination reporter assays to quantify HR efficiency

  • Analyze chromosome aberrations microscopically to assess genomic instability

These approaches should be conducted in parallel with appropriate controls to distinguish NSMCE1-specific effects from general cellular responses to manipulation .

  • How does NSMCE1 interact with the MAGE protein family, and what methodologies can reveal these interactions?

NSMCE1 forms complexes with melanoma antigen proteins (MAGE), particularly with NSMCE3/MAGEG1 in the SMC5/6 complex. To investigate these interactions, researchers should:

  • Perform co-immunoprecipitation assays followed by western blot analysis to identify direct protein-protein interactions

  • Use yeast two-hybrid systems to map specific interaction domains

  • Employ proximity ligation assays to visualize interactions in situ

  • Conduct in vitro binding assays with recombinant proteins to determine binding affinities

  • Apply FRET/BRET techniques to study dynamic interactions in living cells

Of particular interest is the MAGEF1-NSMCE1 ubiquitin ligase complex, which promotes the proteasomal degradation of MMS19, a key component of the cytosolic iron-sulfur protein assembly machinery. This degradation affects DNA repair enzymes dependent on iron-sulfur clusters, including ERCC2/XPD, FANCJ, RTEL1, and POLD1 .

  • What are the optimal methods for investigating NSMCE1-dependent ubiquitination processes?

To study NSMCE1-dependent ubiquitination, researchers should implement a multi-faceted approach:

  • Purify ubiquitin-modified proteins following expression of epitope-tagged ubiquitin in cells

  • Perform in vitro ubiquitination assays using recombinant NSMCE1 and potential substrates

  • Use mass spectrometry to identify ubiquitination sites on target proteins

  • Apply ubiquitin remnant profiling to identify substrates at a proteome-wide scale

  • Compare ubiquitination patterns between wild-type and RING-mutant NSMCE1 expression

Studies have demonstrated the effectiveness of purifying ubiquitin-modified proteins following formation of epitope-tagged ubiquitin in cells to investigate NSMCE1's enzymatic functions .

  • How can researchers address the challenge of studying NSMCE1 in the context of cancer development?

To investigate NSMCE1's role in cancer development, researchers should:

  • Analyze NSMCE1 expression in paired tumor-normal tissue samples from cancer patients

  • Perform survival analysis correlating NSMCE1 expression/mutation with patient outcomes

  • Use cancer cell lines with varying NSMCE1 expression levels to assess proliferation, migration, and invasion capabilities

  • Create xenograft models with NSMCE1-modified cancer cells to study tumor growth in vivo

  • Apply CRISPR screens to identify synthetic lethal interactions with NSMCE1 in cancer contexts

  • Assess how NSMCE1 dysfunction affects response to DNA-damaging chemotherapeutics

Particular attention should be paid to endometrial and esophageal cancers, which have established associations with NSMCE1 .

  • What genomic approaches can researchers use to study NSMCE1 variation in human populations?

To study NSMCE1 variation across human populations, researchers should utilize:

  • Next-generation sequencing data from population databases (e.g., gnomAD, 1000 Genomes)

  • GWAS studies to identify disease-associated NSMCE1 variants

  • Whole exome/genome sequencing of patient cohorts with suspected NSMCE1-related conditions

  • RNA-seq to analyze NSMCE1 expression patterns across tissues and conditions

  • Submit sequence data to repositories like the Genome Sequence Archive for Human (GSA-Human) to facilitate collaborative research

When submitting data to GSA-Human, researchers should include the appropriate citation: "The raw sequence data reported in this paper have been deposited in the Genome Sequence Archive in National Genomics Data Center, China National Center for Bioinformation / Beijing Institute of Genomics, Chinese Academy of Sciences (GSA-Human: HRAxxxxxx) that are publicly accessible at https://ngdc.cncb.ac.cn/gsa-human"[4].

Experimental Design Considerations

  • What are the key considerations when designing CRISPR-Cas9 approaches for NSMCE1 functional studies?

When designing CRISPR-Cas9 experiments for NSMCE1 studies, researchers should:

  • Target early exons (e.g., exon 2 as demonstrated in previous studies) to ensure complete protein disruption

  • Design multiple guide RNAs to increase editing efficiency and minimize off-target effects

  • Include rescue experiments with wild-type NSMCE1 to confirm phenotype specificity

  • Create RING domain mutants (e.g., C191A,C194A) to distinguish between structural and enzymatic functions

  • Establish stable cell lines rather than relying on transient transfection for long-term studies

  • Validate knockouts through both genomic sequencing and protein expression analysis

Previous successful approaches have utilized CRISPR targeting of exon 2 followed by stable transfection of wild-type or mutant NSMCE1 to create comprehensive cell line panels for comparative studies .

  • How should researchers design experiments to study the negative compatibility effect (NCE) in relation to NSMCE1 function?

While the negative compatibility effect (NCE) is primarily studied in masked priming experiments rather than directly relating to NSMCE1, researchers interested in potential connections might:

  • Design priming experiments with varying prime-to-mask intervals (17-50ms) to observe compatibility effects

  • Use compatible, neutral, and incompatible trial types to measure response differences

  • Analyze both reaction times and error rates as demonstrated in previous NCE studies

  • Consider how NSMCE1's role in neuronal function might influence motor control processes

  • Employ forced choice tasks to estimate prime visibility while accounting for prior experience effects

The table below illustrates typical data collection in NCE studies that could be adapted to investigate potential NSMCE1 influence on neural processing:

GroupCompatible RT (ms)Neutral RT (ms)Incompatible RT (ms)Compatible Error (%)Neutral Error (%)Incompatible Error (%)
A (17ms)3463473475.15.06.0
B (33ms)3573563615.34.55.2
C (50ms)3703633603.22.32.0
D (50ms)3533423402.81.61.1

This methodological approach allows for rigorous assessment of compatibility effects under varying conditions .

Product Science Overview

Structure and Function

NSMCE1 is a protein that consists of 266 amino acids and has a molecular mass of approximately 33 kDa . It is typically produced in E. coli and purified using conventional chromatography techniques . The recombinant form of NSMCE1 often includes a His-tag at the N-terminus to facilitate purification .

Role in DNA Repair

The SMC5-SMC6 complex, which includes NSMCE1, is essential for the repair of DNA double-strand breaks. This complex promotes sister chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin complex to the sites of double-strand breaks . This recruitment is crucial for the accurate repair of DNA and the prevention of genomic instability.

Telomere Maintenance

NSMCE1 is also involved in telomere maintenance, particularly in cells that use the alternative lengthening of telomeres (ALT) pathway. In ALT-associated PML bodies (APBs), NSMCE1 mediates the sumoylation of shelterin complex components, leading to the disassembly of the shelterin complex . This process is vital for the maintenance of telomeres and the prevention of chromosomal abnormalities.

Ubiquitin Ligase Activity

In vitro studies have shown that NSMCE1 possesses ubiquitin ligase activity in the presence of NDNL2 . This activity suggests that NSMCE1 may play a role in the regulation of protein degradation and other cellular processes through ubiquitination.

Applications and Research

Recombinant NSMCE1 is widely used in research to study its role in DNA repair, telomere maintenance, and protein ubiquitination. It is also used to investigate the mechanisms of genomic stability and the potential therapeutic targets for diseases related to DNA repair deficiencies.

Storage and Handling

Recombinant NSMCE1 should be stored at 4°C for short-term use and at -20°C for long-term storage. It is important to avoid freeze-thaw cycles to maintain the protein’s stability and functionality .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.